{"disease":{"id":"demyelinating-autoimmune-diseases-cns","name":"demyelinating autoimmune diseases cns"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04386018","title":"A Registered Cohort Study of Inflammatory Demyelination Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Ning Wang, MD., PhD.","has_results":false},{"nct_id":"NCT03297177","title":"Autologous Stem/Stromal Cells in Neurological Disorders and Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Regeneris Medical","has_results":false},{"nct_id":"NCT05982925","title":"Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":170,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT04539002","title":"Aerobic Exercise for Remyelination in Multiple Sclerosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT04762342","title":"Power Training in Older Multiple Sclerosis Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04837651","title":"Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Dragonfly Research, LLC","has_results":false},{"nct_id":"NCT06677710","title":"IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":34,"lead_sponsor_name":"Indapta Therapeutics, INC.","has_results":false},{"nct_id":"NCT05792176","title":"Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT04786821","title":"Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}